Keyphrases
Active Ulcerative Colitis
25%
Adalimumab
75%
Biological Drugs
25%
Clinical Markers
50%
Colectomy
25%
Complex Fistula
50%
Conventional Therapy
25%
Crohn's Disease
25%
Days of Treatment
25%
Diagnostic Imaging
25%
Disease Manifestations
25%
Disease Treatment
25%
Drug Administration
25%
Endoscopy
75%
Fistula
25%
Fistula Repair
25%
Further Treatment
100%
High Dose
25%
Immunosuppressive Therapy
50%
Induction Therapy
75%
Inflammatory Activity
25%
Inflammatory Bowel Disease
100%
Infliximab
100%
Initial Treatment
25%
Maintenance Therapy
100%
Moderate to Severe
25%
MRI Scan
25%
Paraclinical
75%
Partial Response
25%
Perianal Crohn's Disease
25%
Possible Complications
25%
Primary Response
50%
Surgical Treatment
25%
Systemic Steroids
25%
Therapy Effect
25%
Therapy Treatment
25%
Treatment Discontinuation
50%
Treatment Efficacy
50%
Treatment Failure
25%
Treatment Response
25%
Treatment Strategy
100%
Medicine and Dentistry
Adalimumab
75%
Biological Therapy
100%
Colectomy
25%
Combination Therapy
75%
Crohn's Disease
50%
Diagnostic Imaging
25%
Diseases
25%
Drug Administration
25%
Drug Megadose
25%
Endoscopy
75%
Fistula
75%
Ibuprofen
25%
Immunosuppressive Treatment
50%
Infection
25%
Inflammatory Bowel Disease
100%
Infliximab
100%
Infusion
25%
Magnetic Resonance Imaging
25%
Maintenance Therapy
100%
Side Effect
25%
Surgery
25%
Therapy Effect
25%
Treatment Response
25%
Ulcerative Colitis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adalimumab
75%
Combination Therapy
75%
Crohn's Disease
50%
Diseases
25%
Drug Administration
25%
Fistula
75%
Ibuprofen
25%
Immunosuppressive Agent
50%
Infection
25%
Inflammation
25%
Inflammatory Bowel Disease
100%
Infliximab
100%
Side Effect
25%
Ulcerative Colitis
50%